Acuson (US) unveils new transducer:
This article was originally published in Clinica
Executive Summary
Acuson (US) unveiled V4C microCase, its new cardiac imaging transducer, at the American Society of Echocardiography, in Toronto, Canada (June 14th-16th). The transducer is intended for transthoracic stress-test imaging. It switches between three frequencies - 4, 3.5 and 2.5 MHz - which allows it to image adults with tight rib spacing, by reducing shadowing. Acuson says the ergonomics of the V4C make it easier to manipulate and a smaller rounder tip makes switching between views much simpler.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.